Primary human iNKT cells were initially purified from PBMCs or thymi using anti-iNKT MicroBeads (clone 6B11, Miltenyi Biotec, Auburn, CA). Subsequently, the cells were stained with anti-Vα24 (clone C15) and anti-Vβ11 mAbs. The double positive population was sorted with a FACSAria (BD Biosciences, Mississauga, Canada). The purity of the sorted cells was consistently >95%. TCRβ sequencing was performed at Adaptive Biotech using the ImmunoSEQ platform (Seattle, WA). This method was used to capture the frequencies of individual TCRs in biologic samples with accurate reproducibility and a sensitivity of 1/100,000 T cells (26 (link)).